N4 Pharma Plc carries a market capitalization of 3.95M, placing it among publicly traded companies globally.
| Market Cap | 3.95M |
| Enterprise Value | N/A |
N4 Pharma Plc's stock has gained approximately 26.66667% over the past 52 weeks. The 50-day moving average sits at 0.49, while the 200-day moving average is 0.51.
| Beta (5Y) | N/A |
| 52-Week Price Change | 26.66667% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.51 |
| Average Volume (20 Days) | N/A |
N4 Pharma Plc's most recent stock split took place on May 3, 2017 with a 4:1 split ratio.
| Last Split Date | 5/3/2017 |
| Split Ratio | 4:1 |